LUCENTIS (RANIBIZUMAB)

**Product type:** Human Prescription Drug

**Active ingredient:** RANIBIZUMAB

**Strength:** 6 mg/mL

**Dosage form:** Injection, Solution

**Route:** Intravitreal

**Labeler:** Genentech, Inc.

**Marketing category:** BLA (BLA125156)

**Pharmacologic class:** Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]